302.1500 -1.90 (-0.62%)
NSE Jan 02, 2026 15:31 PM
Volume: 57,382
 

302.15
-0.62%
Emkay
Advanced Enzymes' (ADVENZY) Q4FY18 results were in line with our estimate. Revenue stood at Rs1.08bn, up 26% yoy (Emkay Est: Rs1.08bn). US, India, Asia, Europe and Others geographies grew by 36%, 7%, 281%, 27% and 154% yoy, respectively. Revenue growth was driven by Human Nutrition (+36% yoy | 76% of revenue), Industrial Processing (+27% yoy | 5% of Rev.) and Animal Healthcare (5% yoy | 14% of Rev);...
Advanced Enzyme Technologies Ltd. is trading below all available SMAs
More from Advanced Enzyme Technologies Ltd.
Recommended